Erasca to Present at the Bank of America Securities 2023 Health Care Conference
Erasca, Inc. will participate in a fireside chat and investor meetings at the Bank of America Securities 2023 Health Care Conference.
Positive
Participation in the conference could positively impact investor sentiment and potentially increase stock price.
05/02/2023 - 08:00 AM
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in a fireside chat on Tuesday, May 9, 2023, at 2:20 pm Pacific Time at the Bank of America Securities 2023 Health Care Conference, which is being held at the Encore Hotel, Las Vegas, NV. Management will also participate in one-on-one investor meetings.
An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events .
About Erasca At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled what we believe to be the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
Contact: Joyce Allaire LifeSci Advisors, LLC jallaire@lifesciadvisors.com
Source: Erasca, Inc.
The conference is being held at the Encore Hotel in Las Vegas, NV on Tuesday, May 9, 2023.
Yes, Erasca, Inc. will participate in a fireside chat and one-on-one investor meetings.
An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.
ERAS Rankings
#5244 Ranked by Stock Gains
ERAS Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Country
US
City
San Diego
About ERAS
our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.